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THE EFFECT OF GENETIC VARIANCE ON FRACTURE HEALING AS 
ASSESSED BY CALLUS COMPOSITION AND STRENGTH 
ALEXANDER C. WULFF 
ABSTRACT 
Bones have a large capacity for repair and regeneration after an injury. 5-10% of 
the nearly 8 million fractures that occur every year in the United States do not heal 
properly. Bone repair and regeneration is a complex process that utilizes molecular and 
cellular interactions to return to its original structure. Phosphate is essential for healthy 
bone growth and when phosphate deficient it has been shown to impair the process of 
fracture healing. It is unknown if replenishing phosphate to the diet will help return the 
injured bone to its original properties. Some of the differences in fracture repair may be 
due to genetic variability that contributes to morphology of bone and fracture healing. 
This study was carried out to assess how genetic variability affects the process of fracture 
healing.  
To determine how genetic differences interact with phosphate deficiency fractures 
were generated in three different inbred mouse strain (A/J (AJ), C57BL/6J (B6), 
C3H/HeJ (C3)) that had previously been shown to have different endochondral bone 
formation. Animals were placed on a phosphate restricted diet two days prior to fracture, 
and was maintained for 15 days, which covered the normal duration of endochondral 
bone development. To determine if replenishing phosphate in the diet could recover the 
normal healing, phosphate was returned to the diet after 15 days. There was also control 
groups that were on a regular diet for the entire time of the study, which was used for 
	  	   vii 
comparison. Micro-computed tomography (micro-CT), biomechanical torsion testing, 
and contrast enhanced micro-computed tomography (CECT) were methods used to asses 
the properties of the callus over the course of fracture healing.  
Micro-CT and mechanical test results showed that there were significant 
differences within AJ, B6, and C3 strains of mice at the various post-operative day (POD) 
time points. Results from micro-CT data showed that as the POD time point increased 
there was an increase in the amount of mineralized tissue and a decrease in fracture 
callus. These results were confirmed by with the increase in strength measurements from 
mechanical testing conclusions. Further, the fracture callus is less rigid at the early time 
points and as the fracture callus becomes mineralized there is an increase in the rigidity 
measures. Other measures of mechanical properties showed that there were significant 
differences in the B6 and C3 strains of mice among the various POD time points and 
control and phosphate restricted diets. Assessing cartilage content via CECT showed that 
there were significant differences in the control and phosphate restricted diets at POD 14, 
however many of these differences were recovered at the later time points. Visualization 
of the fracture callus using CECT confirmed that there was diminishing cartilage present 
in the fracture callus.  
These results provide insight into the fracture healing process and much 
information about the return of stability and strength to the fractured bone. Taken 
together, the outcomes of this study indicate that the bones heal and mechanical strength 
is recovered once the phosphate has been added back into the diet.   
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INTRODUCTION 
The skeleton is a very important component of the human body and is constantly 
undergoing repair and remodeling throughout life. Fractures are a common occurrence 
and 5-10% of the estimated 5.6 million fractures that occur every year in the United 
States are delayed or impaired (Einhorn, 1995) When a fracture occurs it begins a process 
of molecular and cellular events that repeat the process of embryonic endochondral bone 
formation (Wigner et al., 2010). The process of bone regeneration represents a well-
organized series of biological events of cellular recruitment, proliferation, and 
differentiation. The healing process is affected by several factors; among these factors are 
fixation method and properties of the bone. When a bone heals there may be mechanical 
strength differences from the original property of the bone prior to fracture. The extent of 
mechanical stability that can be achieved at the fracture site is relevant to the type of 
fixation method that is selected (Giannoudis, Jones, & Einhorn, 2011). One of the clear 
links to impaired fracture healing is hypophosphatemia, a feature of several congenital 
rachitic disorders (Wigner et al., 2010). This study focuses on how differences in genetic 
variation interact with hypophosphatemia and effect the regain of mechanical strength as 
the fracture heals. 
Process of Normal Fracture Healing 
Bone has a great capacity to repair and regenerate in response to injury or surgery. 
Both of these processes involve a complex integration of cells and other biological 
components (AI-Aql, Alagl, Graves, Gerstenfeld, & Einhorn, 2008). When bone repairs 
itself the stability of the tissues injured are restored. During regeneration there is 
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differentiation of cells that forms new bone tissue, which results in the additional volume 
of skeletal tissues (AI-Aql et al., 2008). Figure 1 illustrates the four areas that are 
contiguous with the fracture site and interact to begin the process of fracture healing. 
These are the external soft tissue, the periosteum, the cortical bone, and the bone marrow 
space. This response is what is responsible for producing the cartilage surrounding the 
fracture line that will provide the support structure of the fracture callus.  
 
Figure 1. Sites involved in Fracture Healing. Figure taken from Einhorn, 1995  
The process of fracture healing can either be described as primary or secondary 
fracture healing (L. C. Gerstenfeld & Einhorn, 2003). Primary fracture healing involves a 
direct attempt by the cortex to heal itself after interruption without the formation of the 
fracture callus. This only takes place when the edges are touching exactly which is not a 
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common occurrence. Hence, primary fracture repair is uncommon unless the fracture 
bone is rigidly fixed. Secondary fracture healing is more likely to be the major form of 
fracture healing. This involves the classical stages of healing: injury, hemorrhage 
inflammation, primary soft callus formation, callus mineralization, and callus remodeling 
(Berstein, 2011). Secondary fracture healing closely resembles endochondral ossification. 
From this it is suggested that the process of indirect bone healing results in the 
reformation of bone that is of the same mechanical strength of the original bone or even 
stronger (Berstein, 2011). Endochondral ossification involves the recruitment, 
proliferation, and differentiation of undifferentiated mesenchymal cells into cartilage, 
which becomes calcified and eventually is replaced by bone (Dimitriou, Tsiridis, & 
Giannoudis, 2005). The initial response to fracture healing for secondary fracture healing 
involves the formation of a hematoma around the bone marrow space due to the damage 
to the blood vessels in the area of the fracture. After the formation of the hematoma, the 
damaged blood vessels are removed from the area of the fracture to allow the next 
cascade of events to occur. A fibrin clot is established and cells are arranged close to the 
fracture site that allow for the remodeling of the fracture into cartilage, which is then 
calcified into bone (Brighton & Hunt, 1991). It has been shown that this process utilizes 
both primary and secondary means of fracture healing (Louis C. Gerstenfeld, Cullinane, 
Barnes, Graves, & Einhorn, 2003).  
Another approach to bone formation is intramembranous ossification. 
Intramembranous ossification involves the formation of bone directly, without first 
forming cartilage, from committed osteoprogenitor and undifferentiated mesenchymal 
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cells that reside in the periosteum farther from the fracture site (L. C. Gerstenfeld & 
Einhorn, 2003). 
 
Figure 2. Anatomical Representation of fracture repair. A. Mid-diaphysial transverse fracture after 14 days with 
representative sagittal and transverse histological sections in upper and lower panels respectively. The transverse 
sections were taken every 1,000 μm with approximate positions shown with dotted line. Sections are stained with 
safrin O and fast green with micrographic images taken at 25 x magnification. The cartilage is stained bright red with 
bone staining pale blue. B. Diagrammatic representations of the fields of tissue development. Sagittal view is in the 
upper panel while the transverse view is in the lower panel. Tissue types are denoted in the figure with the potential 
origins of mesenchymal stem cells and morphogenic signals represented by the orange and green arrows respectively. 
C. Three-dimensional rendering of the spatial orientation of the developing tissues in the fracture callus. The 
developing vascular elements are denoted with the blue arrows. Figure taken from Gerstenfeld et al. 2003. 
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Fracture healing is similar to most other responses in that it starts with the induction of 
the immune response. The beginning stage is when the hematoma occurs and 
inflammation around the fracture occurs. Cytokines, platelets, bone morphogenic proteins 
(BMPs), and mesenchymal stem cells (MSCs) are the major elements of the initial 
inflammatory phase (Dimitriou et al., 2005). One such model of fracture healing that 
developed from histological observations of both human patients and animal models. The 
events that occur during fracture healing are commonly described as overlapping stages 
consisting of inflammation, soft callus formation, hard callus formation, and bone 
remodeling (Schindeler, McDonald, Bokko, & Little, 2008). 
Stage 1: Inflammation 
 Fractures are typically associated with the collapse of the soft tissue integrity, 
interruption of the normal vascular function, and distortion of the morrow structure 
(Schindeler et al., 2008). This process leads to the beginning of the non-specific wound 
healing pathways that accompany non-skeletal damage. Degranulating platelets, 
macrophages, and many other inflammatory cells enter the hematoma between the 
fractured fragments and help to prevent infection, secrete cytokine, growth factors, and 
advance the clotting process (Brighton & Hunt, 1991; Schindeler et al., 2008). Over time 
the capillaries grow into the cloth, which becomes granulated tissue (Schindeler et al., 
2008).  The hematoma that is generated consists of cells from both the peripheral and 
intramedullary blood as well as some bone marrow cells (Marsell & Einhorn, 2011). The 
acute inflammatory response peaks within the first 24 hours and is usually complete 
around seven days.  
	  6 
Stage 2: Soft Callus Formation 
 This stage is dominated on a cellular level by chondrocytes and fibroblasts. The 
cells of this stage produce a soft semi-rigid callus that is able to provide some mechanical 
support to the fracture and can act as a template for the boney callus that will come later. 
This cartilaginous callus is mostly avascular, however the subsequent replacement with 
woven bone involves a vascular invasion (Schindeler et al., 2008). Following the 
formation of the primary hematoma, a fibrin-rich granulation tissue forms and within this 
tissue endochondral formation occurs between the fracture ends and external to periosteal 
sites (Marsell & Einhorn, 2011). These regions are also mechanically less stable and the 
cartilaginous tissue forms a soft callus, which gives some stable structure to the fracture 
(Marsell & Einhorn, 2011). 
Stage 3: Hard Callus Formation 
 This stage is also called the primary bone formation and represents the period 
where osteogenesis is most active. There are typically high levels of osteoblast activity 
and the formation of mineralized bone matrix. This activity arises directly in the 
peripheral callus in areas of stability (Schindeler et al., 2008). Hard callus can form in the 
absence of a cartilaginous template in intramembranous bone formation when the bone is 
mechanically stable or in appositional bone growth where bone forms directly adjacent to 
an existing mineralized surface (Schindeler et al., 2008). Fracture healing requires a 
blood supply and revascularization is needed for this bone growth (Marsell & Einhorn, 
2011). Once the structure is set the vascularization process is mainly regulated by two 
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molecular pathways, an angiopoietin pathway and a vascular endothelial growth factor 
(VEGF) dependent pathway (Marsell & Einhorn, 2011).  
Stage 4: Bone Remodeling 
 The final stage of the fracture repair process is the remodeling of the woven bone 
hard callus into the original cortical and/or trabecular bone. This process involves 
converting the woven bone callus into lamellar bone before the standard cortical structure 
is restored. Osteoclasts are the key cell involved for mineralized bone resorption, it is a 
large multinucleated cell that is formed by the differentiation and fusion of hematopoietic 
precursors (Schindeler et al., 2008). While remodeling bone osteoclasts become polarized 
in order to adhere to the mineralized surface and form a ruffled border, which becomes 
sealed off while acid and proteinases are pumped into the resorption domain (Schindeler 
et al., 2008). Once the bone resorption is completed osteoblasts lay down new bone on 
the surface. This process is usually initiated around 3-4 weeks, however it may take years 
to fully complete and fully regenerate the bone structure (Marsell & Einhorn, 2011).  
The Role of Phosphate in Normal Fracture Healing 
Hypophosphatemia is a feature of several congenital rachitic disorders and has 
been shown to impair the process of fracture healing. Investigators used mouse models of 
hypophosphatemia and vitamin D resistant rickets to demonstrate that rachitic expansion 
of the hypertrophic chondrocyte later in the growth plate is a consequence of the impaired 
apoptosis of these cells. Molecular analysis reveals that increases in extracellular 
phosphate activate the mitochondrial apoptotic pathway, which is a process required for 
normal endochondral bone formation (Schindeler et al., 2008; Wigner et al., 2010). 
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Therefore phosphate plays a regulatory role in terminal differentiation of hypertrophic 
chondrocytes and is required for mineralized matrix formation. Rickets and other 
hypophosphatemic states are associated with impaired fracture healing however it is 
unclear what specific role phosphate plays in this process. These disorders are associated 
with osteomalacia owing to impaired matrix mineralization, which can have an effect on 
fracture healing (Wigner et al., 2010). The regain of bone strength and stiffness are the 
fundamental qualities that define healing, however they are difficult if not impossible to 
measure in a clinical setting. Presently clinical settings rely on qualitative metrics like 
range of motion, discomfort, regain of structural integrity based on plain film x-ray 
(Morgan et al., 2009). Micro-CT provides numerous quantitative and 3D measurements 
of structure and mineralization of fracture callus which could potentially be related to 
callus stiffness and strength (Louis C. Gerstenfeld et al., 2006; Hayward et al., 2012; 
O’Neill et al., 2012). This may lead to the development of reliable non-invasive metrics 
of healing (Morgan et al., 2009). 
Genetic Variation in Fracture Healing 
 When studying fracture healing it is important to look at multiple genetic models 
in order to get a grasp of the complexities that are involved in fracture healing. There are 
a number of inbred mouse strains that have been used to study the multiple intricacies of 
the fracture healing process (Jepsen et al., 2008). In past studies the mouse strains A/J 
(AJ), C57BL/6J (B6), and C3H/HeJ (C3) have been used to explore the genetic 
relationship between the repair mechanisms and the expression of proteins and 
transcription factors that are involved in the process of fracture repair. The B6 mouse 
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strain exhibits a faster progression of endochondral bone formation compared to the other 
two mouse strains (Jepsen et al., 2008). The mouse models differ in their rates of 
cartilage development as well as differences in the expression of various genes involved 
in fracture healing. This has provided insight into the ways these mice strains heal at 
different rates as well as differences in mineralization, and callus size (Jepsen et al., 
2008). 
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Figure 3. Comparison of Control and Phosphate Restricted Calluses. I. AJ mice fracture calluses at post operative 
day 14, 21, 35, and 42 for the control strain (A) and the phosphate restricted strain (B). II. B6 mice fracture calluses at 
post operative day 14, 21, 35, and 42 for the control strain (A) and the phosphate restricted strain (B). III. C3 mice 
fracture calluses at post operative day 14, 21, 35, and 42 for the control stain (A) and the phosphate restricted strain 
(B).  	    
I	   II	  
III	  
III	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OBJECTIVES 
 The overall goal of this study was to examine the effect of the interaction of 
genetic variation with environmental variation on fracture healing. This was assessed by 
measuring the composition and mechanical strength of the fracture callus over a time 
course of healing in three inbred mouse strains, A/J (AJ), C57BL/6J (B6), and C3H/HeJ 
(C3) under normal and phosphate deficient conditions. To test callus composition and 
mechanical strength two groups of mice were enrolled, the first group were placed on a 
phosphate deficient diet two days prior to fracture and were placed back on a normal diet 
after 15 days, while the second, control group, were provided with a normal diet 
throughout experiment. The specific aims were to assess the effect of phosphate 
deficiency and genetic variability on:  
 1) Mineralization and mechanical strength of the callus: Mineral content and 
mechanical strength of the calluses were assessed using images from micro-computed 
tomography (micro-CT) and mechanical torsion testing. All three strains of mice were 
used to compare differences in the mechanical strength of the callus with phosphate 
deficiency and the same strain without phosphate restriction. The images from micro-CT 
were analyzed for overall differences in structural properties and mineral content of the 
calluses from the three strains of mice. 
2) Cartilage content: Contrast enhanced micro-computed tomography (CECT) 
was used to assess cartilage composition of the fracture callus at various time points 
among the three strains. Phosphate restricted strains of mice were compared to non-
restricted mice of the genetic strain. From this measurement it was possible to examine 
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the progression in cartilage composition within each strain as well as compare among all 
three strains the composition of the fracture callus.  
It is currently understood that there is genetic diversity among humans and this 
alters the manner in which fracture healing occurs, however we do not fully understand 
the effects of the diversity on mechanical properties. In order to better understand this 
question we explored the effect of phosphate restriction followed by a return to normal 
diet in three strains of mice. From this experiment we hope to learn more about fracture 
healing and to what degree phosphate restriction impairs or hinders healing. It is from 
this information that we hope to learn more about the regain of mechanical strength of 
bone after healing because this is difficult if not impossible to measure in a clinical 
setting. We are hoping to get a better understanding of the mechanical properties in order 
to apply this information to the clinical aspect of fracture repair. This information will 
potentially give rise to new insight and provide knowledge to the scientific community 
who are concerned with helping humans with impaired fracture healing due to 
deficiencies in phosphate.  
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METHODS  
A/J (AJ), C57BL/6J (B6), and C3H/HeJ (C3) mice were used to test the 
hypothesis. One group of mice were placed on a 15-day phosphate restricted diet that 
began two days prior to fracture while the other group, control group, was placed on a 
normal diet throughout. Within each strain 14-day, 21-day, 35-day, and 42-day post 
fracture time points of both control and 15-day phosphate restricted mice were assessed. 
These time points were chosen for the study to survey the overall picture of the fracture 
callus formation and transition to calcified bone. Around the 42-day post fracture time 
point the femur should be almost completely healed. 
Animals 
 A total of 450 mice were used throughout the course of this study. The strains of 
the mice used for the duration of the study were A/J (AJ), C57BL/6J (B6), and C3H/HeJ 
(C3). Jackson Laboratories (Bar Harbor, Maine) supplied the mice, which were brought 
to Boston University School of Medicine Laboratory Animal Sciences Center (LASC). 
After the mice arrived as the LASC they were placed on the phosphate restrictive diet. 
The mice that were enrolled in the study were 8-10 weeks old. Only male mice were used 
in order to minimize the differences in sex associated with fracture healing such as the 
effect of estrogen on bone metabolism (Jepsen et al., 2008). 
Phosphate Diet Restriction 
 Two experimental groups were included for all strains of mice. The first group 
was placed on a phosphate deficient diet. The mouse diets, Special Custom Animal 
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Research Diets, were obtained from Harlan Laboratories® PO Box 44220 Madison, WI 
53744-4220. The diet is TD.033486 EW Diet, which is 20% Lactose, 0.6% Calcium, 
Low Phosphate provided as a standard caloric formulation that was supplemented with 
vitamins but deficient in phosphate. The mice were placed on the phosphate restricted 
diet two days prior to fracture on the right femur and maintained the diet until after 15 
days of phosphate restriction at which point they were then returned to the normal diet, 
which consisted of standard mouse chow (Purina Mills Inc., St. Louis, MO, USA) feed 
and water was continuously available. The second group of mice was provided with 
normal diet throughout the experiment. 
Surgical Procedure 
 All of the mice underwent surgery at the LASC from an approved protocol by the 
Institutional Animal Care and Use Committee (IACUC). The LASC facility is an 
approved facility by the American Association for the Accreditation of Laboratory 
Animal Care (AAALAC) and is licensed by the United States Department of Agriculture 
(USDA). All Boston University School of Medicine personal that worked with the 
animals were approved by these regulatory agencies to use the facility.  
 Prior to surgery the animals were anesthetized using an inhalation of isoflurane 
and oxygen mixture. The mixture was 5% isoflurane until anesthetized and maintained at 
3% during the procedure via a nose cone. The mice were given a dose of .1mg/kg of 
Bupranex® (buprenorphine) and antibiotic Baytril® (enrofloxacin) at a dose of 0.01 
mg/kg. These drugs were delivered subcutaneously prior to the surgery to ensure post-
operative pain management and prophylactic infection control. For the procedure the 
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right knee was aseptically prepared by scrubbing the area with gauze that was soaked in 
Betadine® (povidone-iodine) before it was shaved with an electric shaver. 
 Once the mouse knee was shaved and prepared a small longitudinal incision was 
made over the patellar ligament of the right knee. The knee was opened so that the 
femoral condyle was exposed and a small hole was made with a 23 gauge spinal needle. 
The spinal needle was then placed down the hole until it reached the proximal physis. At 
this point the needle was cut at the femoral condyle and pushed under the surface so that 
the wound could be closed with 3 to 4 absorbable sutures. After the pin was in place the 
mouse femur was ready for fracture.  
 The machine that is used to fracture the mice femurs has a blunt blade that is 
dropped by a weight from a set height. A modification of the machine described by 
Maturano et al., 2008 was used to create the fractures. The blunt blade is spring loaded 
and controlled via a foot pedal. The animals were positioned so that their femur was 
under the blunt blade on a mount with two points of contact. The femur was positioned so 
that the blunt blade when dropped would contact the mid-diaphyseal section of the bone. 
Once the animal was correctly in place under the mechanism the blade was dropped in a 
manner the replicated the action of a guillotine to create a three point bending and create 
a fracture.  
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Figure 4. Fracture Machine Design. (Left) Scale model of mouse fracture device with an adjustable mass shaft and 
stop mechanism held up by an electromagnet above a base that is adjustable for height. The blunt striker hits impacts 
the mouse femur that is held in place by the mouse positioning system. (Right) Photograph of the built mouse fracture 
device with electromagnet foot pedal switch, dimensions of the device are 37” x 12” 12”. Figures 4 taken from 
(Marturano et al., 2008). 
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Figure 5. Close Up of Mouse Positioning System in Fracture Mechanism. (Left) Scale model of mouse positioning 
system with the half-pipe arc track that the torso of the mouse sits in and swivels on a 120° arc track depending on the 
desired fracture leg. The femur is positioned perpendicular to the striker using the anvil notches. The entire mechanism 
is adjustable using a four-post bolt system, which allows there to be different velocities at impact. (Right) Photograph 
of the built mouse positioning system with mouse in place. Figures 5 taken from (Marturano et al., 2008). 
 The blunt blade created a single transverse closed fracture. After the fracture an 
initial assessment was done via palpation of the area. The mouse was then placed for 
confirmation of fracture by using a dental x-ray unit to ensure there was a fracture with 
no pin retraction. The x-ray device was purchased by Gendex, Inc. and was housed in the 
LASC procedure room. Mouse femur x-rays were taken at a setting of 60kV for 0.16 
seconds using Kodak Ultra Speed DF-50 size 4 films. If there was an animal that did not 
have a fracture, they were anesthetized again and placed on the fracture machine. A 
second x-ray was also taken to confirm the fracture.  
Post-Operative Treatment 
 Immediately after the confirmation of fracture x-ray was taken the mice were 
monitored until they regained consciousness from anesthesia. This was determined by 
their ability to walk at which point they were moved to a new clean cage with fresh food 
and water. The following day the animals were monitored and given injections of 
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0.1mg/kg of buprenorphine as an analgesic. Mice were examined daily for signs of pin 
retraction, nerve damage, and any other signs of failure to recover from the surgery and 
fracture process. After the predetermined amount of time the mice were removed from 
their phosphate restriction diet and returned to a normal diet depending on which group 
they were enrolled.  
Femoral Harvesting 
 When a group of mice for a given time point reached the predetermined time, 
shown in table 1 and 2, they were taken from LASC and brought to the Boston University 
School of Medicine Department of Orthopaedic Surgery Laboratory for euthanasia.  
Table 1. Mechanical Testing and Micro-CT Sample Groups. A total of two groups (phosphate deficient and control) 
were used for mechanical testing studies. For each strain (AJ, B6, C3) and each post operative day (POD) or time from 
fracture both groups were tested.  
	   	   Strain	  
PO
D
	  
	  	   AJ	   B6	   C3	  
14	   Pi/C	   Pi/C	   Pi/C	  
21	   Pi/C	   Pi/C	   Pi/C	  
35	   Pi/C	   Pi/C	   Pi/C	  
42	   Pi/C	   Pi/C	   Pi/C	  
 
Euthanasia was accomplished by carbon dioxide inhalation. Mice were taken one by one 
and placed in an approved chamber where a carbon dioxide flow rate of 20% per minute 
was initiated. After they were taken out of carbon dioxide chamber cervical dislocation 
was performed as a secondary euthanasia procedure. X-rays were taken of the femur 
being harvested immediately following cervical dislocation. A Faxitron MX-20 Specimen 
Radiography System was used for x-rays for a time of 40 seconds at 30 kV and a distance 
of about 13 cm. Kodak BioMax XAR Scientific Imaging film was used for the x-rays.  
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 To remove the femur a small incision was made in the skin above the right femur 
and forceps were used to remove the superficial layer of skin to expose the muscle. 
Hemipelvectomy and disarticulation of the knee were performed to remove the femur 
from the mice. After the femur was removed the spinal needle pin was removed using 
forceps. The surrounding soft tissue was removed and care was taken so as to not damage 
the fracture callus using a scalpel, wrapped in gauze, and placed into tubes, which were 
properly labeled with animal identification number and were designated to either micro-
CT, CECT, or mechanical testing. Once in the tube it was placed in a liquid nitrogen bath 
until all samples were harvested and transferred to storage in -80° Celsius until they were 
ready to be scanned and tested.  
 In this study samples were stored at -80° Celsius, which is not the common 
practice. Traditionally samples used for testing the mechanical strength are stored at -20° 
Celsius. Six mice without fractures were used to collect 6 femurs by the same procedure 
and placed in tubes, which were then placed in an ice bath before being stored in a -20° 
Celsius freezer, the other 6 femurs were placed in liquid nitrogen before being stored in 
the -80° Celsius freezer. This was done to compare the freezing and storage process of 
liquid nitrogen and the -80° Celsius freezer for potential to alter the mechanical 
properties of the tissue as the -20° Celsius freezer is the commonly used approach in 
literature.  
Micro-CT Imaging 
 Micro-computed tomography (Micro-CT) is a more advanced method than plain 
X-ray that provides three-dimensional, high-resolution images of the bone whereas X-
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rays are limited to a two-dimensional assessment of a three-dimensional fracture callus. 
Along with mechanical properties of the callus, these measurements can be used to study 
the cartilage content and the amount of mineralization of the fracture callus. Once the 
relationships are established it is possible to predict the callus strength based on these 
micro-CT measurements (Morgan et al., 2009; O’Neill et al., 2012). 
 The samples were removed from the freezer and allowed to thaw in phosphate 
buffered solution (PBS) prior to imaging. They were unwrapped and any excess soft 
tissue was removed by scalpel. The femurs were then placed into a piece of Styrofoam 
and placed in a radiolucent sample holder that was compatible with the CT scanner. The 
foam was used to stabilize the sample while the scan was performed to eliminate motion 
artifacts.  
 Scans were performed using a Scanco micro-CT 40 system (Scanco Medical, 
Basserdorf, Switzerland) at 12 m/voxel resolution with 200 ms integration time using the 
conditions of 70 kVp and 114 mA. The reference line (seen in figure 6) for where the 
scan would start and stop was adjusted on each individual bone to include the entire 
callus area. The transverse images were then reconstructed digitally to generate a 3D 
image of the fracture callus. Analysis of the bone was done using Scanco Medical 
software. All of the specimens had a global threshold algorithm that was used to apply a 
fixed constant threshold (Morgan et al., 2009). 
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Figure 6. Scout View of Micro-CT Sample. Image shows two femurs stacked vertically. Two horizontal lines on the 
bottom femur are drawn to show the start and stop sections of the scans. The area between the lines is supposed to 
represent the fracture callus.  
 In order to extract the callus from the surrounding foam, the outer surface of the 
callus was traced using software that is included in the Scanco system. The same 
software was used to trace and exclude the pre-existing cortex and bone fragments that 
were present. Thus, only callus tissue was analyzed. 
 Using the micro-CT images and built-in algorithms, the following measures of 
callus structure and composition were quantified for the fracture calluses of each 
specimen: total callus volume (TV); mineralized callus volume (BV); bone volume 
fraction (BV/TV); tissue mineral density (TMD); and bone mineral density (BMD). 
Tissue mineral density is calculated as average density of mineralized tissue pixels within 
the contours that are above the applied threshold determined by an earlier evaluation. In 
comparison, the bone mineral density is the average density of all the pixels within the 
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applied contours. Prior to computing the values for each of these measurements, a 
Gaussian filter (sigma = 0.8, support = 1.0) was applied in order to reduce the noise. 
Calculation of TMD and BMD was accomplished by density calibration data that was 
obtained from scans of a hydroxyapatite (HA) phantom provided by the system 
manufacturer (Morgan et al., 2009). 
Mechanical Testing 
 After the imaging was complete the samples were prepared for mechanical testing 
by potting the proximal and distal ends in polymethyl methacrylate (PMMA). The potting 
process used end caps of 10 mm square (10 x 10 mm2) aluminum tubing. To place the 
bones in the PMMA solution the proximal and distal ends of the femur were first dipped 
in ethyl alcohol for 15 seconds followed by PBS for 20 second. Femurs were placed in 
the center of the square end caps and held in place by forceps and clamps held to a stand. 
This set up can be visualized in Figure 5. Once the first end cap’s PMMA dried then the 
bone could be placed in the second end cap and held in place with clamps to a stand to 
ensure alignment with the first end cap. Once both end caps’ PMMA was dry the L-
shaped stand was removed. The region between the PMMA of the two end caps was 
measured and defined as the gauge length. Four measurements were taken at 90° 
increments around the circumference and the average taken for the most accurate gauge 
length. The completed specimens were then mounted into the Instron testing system 
(MT55, Instron, Norwood, MA) and the end caps were secured in place using the system 
grips.  
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 Angular displacement or twisting was then applied to each sample was then 
applied at a rate of 0.5°/second until failure at the fracture. The rotation was applied to 
each sample so that the distal end of each femur was rotated inward relative to the 
proximal end. The Instron machine is shown in figure 8.  
 
Figure 7. Close Up of PMMA Potting Technique. These pictures are close up images taken of the PMMA potting 
technique. Instead of rubber bands clamps were used to keep aluminum cubes in place against the stand. Rubber bands 
are shown here in order to better visualize the bone in the PMMA.  
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Figure 8. Instron Torsion Testing System. Photo of the Instron torsion testing machine that was used for 
mechanically testing all femur samples.  
The torque was measured with a 2.25-Nm transducer and angular displacement 
with an optical encoder (Morgan et al., 2009). Torsional strength was defined as the 
maximum torque sustained by the specimen. Torsional stiffness was calculated as the 
slope of the linear portion of the torque-twist curve with gauge length normalizing the 
twist portion of the curve. When measuring the torsional stiffness two measurements 
were used, one was the “narrow” which was calculated using the linear portion of the 
torque-twist curve, while the other measurement “break” used the entire curve until the 
maximum torque was reached. Torsional rigidity is the force applied per radians of the 
turn. Work to failure was defined as the area under the torque-twist curve up to the point 
failure occurred. 
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Figure 9. Torsional Strength Curves. (A) Torque vs. twist curve showing the torsional strength region for the narrow 
measurement of both stiffness and rigidity. (B) Torque vs. twist curve showing the torsional strength region for the 
break measurement of both stiffness and rigidity. 
Contrast Enhanced CT Imaging (CECT) 
 Contrast enhanced CT scanning was performed on three time points for all three 
strains of mice both phosphate restricted as well as the control of normal diet. For each 
time point nine mice were scanned for a total of 162 mice. Femur fracture calluses were 
scanned using the Micro-CT 40 (Scanco Medical) and placed in PBS with protease 
inhibitor and pen-strep to prevent degradation of the sample. A resolution of 12 
µm/voxel, peak voltage of 70kV, current of 114mA, and an integration time of 200 ms 
were used for the scan settings. After the scan was complete, the fracture callus was 
incubated in a cationic contrast agent (CA4+) shown in figure 7 for 8 hours at room 
temperature. A post-incubation scan was then carried out using the same scan setting.  
A B 
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Figure 10. Molecular Structure of the Contrast Agent. Figure was taken Hayward et al., 2013 
 The image analysis used in this study was adapted and modified from the one 
presented in the paper by Hayward et al. 2013. Stacks of transverse dicom files from the 
pre and post-incubation in contrast agent scans of each sample were imported into the 
Amira software program (Amira 5.5, Visage Imaging, Andover, MA) for alignment to the 
original pre-incubation scan. Once the images were aligned and registered the pre images 
were subtracted from the registered post-incubation images to produce a subtracted 
image. The resulting images were then analyzed to determine cartilaginous tissue from 
non-cartilaginous tissue by determining the threshold of callus and bone, which was then 
applied to the subtracted image. This was accomplished by examining the range of 
intensities (upper and lower thresholds) in the subtracted images that identified cartilage. 
The thresholds were calculated by the analysis of the histogram of the intensities for each 
femur fracture sample. Upper thresholds were only applied when there was bone present 
in the subtracted image.  
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Figure 11. Histograms and Probabilities for CECT. (A) Histogram for a 3-part fit image subtraction. (B) Probability 
graph for 3-part fit of histogram in part A. (C) Histogram for a 4-part fit image subtraction. (D) Probability graph for 4-
part fit of histogram in part C. 
Each histogram was broken down into the sum of three or four normal distributions that 
corresponded to intensities that represented background noise, PBS and non-cartilaginous 
soft tissues, cartilage, and bone. Thresholds were chosen so that 95% of the voxels with a 
given intensity over the lower threshold and greater than 50% of the voxels with a given 
intensity under the upper threshold correspond to the cartilage composition of the fracture 
callus.  
Statistical Methods 
 Three-factor analysis of variance (ANOVA) was done for each measurement 
using JMP (JMP 9.0, SAS Institute Inc., Cary, NC). Strain, diet, and post-operative day 
of callus formation were used as the variables in the ANOVA testing. For significant 
A B 
C D 
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factors, a post-hoc comparison using Tukey HSD was performed. A significance level of 
0.05 was used for all statistical analyses.  
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RESULTS 
 
Micro-CT Testing Analysis 
 Micro-CT analysis showed many significant differences as well as significant 
interactions between the factors. For example POD, strain, and POD crossed with diet 
were significant for all measures of micro-CT analysis, while diet crossed with strain did 
not show any significance for the measurements of micro-CT.  
Table 2. Micro-CT ANOVA Significances. Results from ANOVA and post-hoc Tukey HSD test for significance of 
the micro-CT data. Significant p-values are highlighted in yellow with the calculated p-value in the box. 
	  	  
TV	  	  
[mm3]	  
BV	  	  
[mm3]	  
BV/TV	  
[-­‐]	  
BMD	  	  
[mg	  HA/cm3]	  
TMD	  	  
[mg	  HA/cm3]	  
POD	   <.0001	   <.0001	   <.0001	   <.0001	   <.0001	  
Strain	   <.0001	   <.0001	   <.0001	   <.0001	   <.0001	  
Diet	   0.743	   0.4074	   0.0011	   <.0001	   <.0001	  
POD*Strain	   0.6612	   0.0002	   <.0001	   <.0001	   <.0001	  
POD*Diet	   <.0001	   <.0001	   0.0015	   <.0001	   <.0001	  
Strain*Diet	   0.0927	   0.1517	   0.6315	   0.5208	   0.4995	  
Strain*Diet*POD	   0.4968	   0.0044	   0.0061	   0.0004	   <.0001	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Figure 12. Total Volume Measurements for AJ, B6, C3. Comparisons between POD and diet are shown for total 
volume (TV) of callus measurement. Statistical significance is shown between points by a line with a * above. 
 Total volume (TV) is a measure of the total volume of all the tissues of the callus. 
There were no significant differences in the AJ strain. B6 strain showed significant 
difference between POD 14 control and POD 21 control as well as both control and 
phosphate restricted for POD 35. POD 14 phosphate restricted was significantly different 
from POD 35 control in B6. There was also significant difference between POD 21 
control and phosphate restricted and POD 35 control. The only significant difference that 
could be seen in the C3 strain was between POD 14 control and POD 35 both control and 
phosphate restricted diet groups. Overall for all three strains there is a trend of decreasing 
TV as the length of POD time increased. The TV comparisons for POD 42 can be seen in 
figure 13.  
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Figure 13. Total Volume comparison for POD 42. Comparisons of each strain against control and phosphate 
restricted diets for POD 42.  
 When comparisons were done among all the strains at POD 42 time point there 
was no significant differences found.  
 
 
 
 
 
Figure 14. Bone Volume Measurements for AJ, B6, and C3. Comparisons between POD and diet for bone volume 
(BV) for each strain are shown. Significance between points is show by a line with * above. 
 Bone volume (BV) is a measure of the amount of bone, determined by a set 
threshold, which makes up the composition of the fracture callus. There were significant 
differences in each strain. AJ strain showed significant differences between POD 14 
	  32 
phosphate deficient and POD 21 and POD 35 both control and phosphate deficient. B6 
mice showed a lot of significant differences. POD 14 control to POD 35 phosphate 
restricted were significantly different. Both POD 14 control and phosphate restricted 
were significantly different from both the control and phosphate restricted POD 21. POD 
14 phosphate restriction was significantly different from both control and phosphate 
restricted POD 35. POD 21 was significantly different from POD 35 control as well as 
POD 21 control. For the C3 strain of mice POD 14 phosphate restricted diet was 
significantly different from POD 35 control and both control and phosphate restricted 
groups of POD 21. Overall there is a trend of increasing BV as the POD time increased 
 
Figure 15. Bone Volume comparison at POD 42. Comparison of each strain against control and phosphate restricted 
diet at POD 42.  
 Comparison of each of the strains against diet at POD 42 there was so significant 
difference between the measures.  
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Figure 16. Bone Volume/Total Volume Measurements for AJ, B6, and C3. Comparisons between the POD and diet 
for the measurement of bone volume/total volume is shown. Significance between POD and diet are shown by 
connected lines with a * above.  
 Bone volume/total volume (BV/TV) is a measure of the mineralized volume 
fraction. There were a lot of significant different between POD time points for each 
strain. AJ strain showed statistically significant differences between POD 14 control and 
POD 21 phosphate restricted and POD 35 control. POD 14 phosphate restricted was also 
significantly different from both POD 21 and POD 35 control and phosphate restricted. 
AJ POD 35 phosphate restricted group was also significantly different from both control 
and phosphate restricted POD 21. The B6 group POD 14 control and phosphate restricted 
was significant with both control and phosphate restricted POD 35. POD 14 control also 
showed to be significantly different from POD 21 control. There were also significant 
differences between POD 14 phosphate restricted and both control and phosphate 
restricted POD 21. For the C3 strain there were a lot of statistically significant 
differences. POD 14 control was significantly different from POD 35 phosphate restricted 
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group. POD 35 phosphate restricted died group was significantly different from POD 21 
control. POD 35 control was significantly different from both the control and phosphate 
restricted diet groups of POD 14 and POD 21. POD 14 control and phosphate restricted 
diet groups were both significantly different from both diet groups of POD 21. Overall 
the ratio of BV/TV increased for all three strains as the POD time increased. 
 
Figure 17. Bone Volume/Total Volume Comparisons at POD 42. Comparison of each strain against the control and 
phosphate restricted diet groups for BV/TV at POD 42. 
 Comparison of POD 42 against each diet group (control and phosphate restricted) 
for each of the three strains of the measurement BV/TV, which did not show any 
significant differences.  
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Figure 18. Bone Mineral Density for AJ, B6, and C3. Comparisons between POD and diet for the measurement of 
bone mineral density (BMD). Significance is shown between POD and diet group by a line connecting the points with a 
* above. 
 Bone mineral density (BMD) is an average voxel density in a defined region of 
interest. This measurement contains a mixture of bone, soft tissue, and marrow. In this 
study we excluded the canal and bone cortex. There were significant differences in all 
three strains. The AJ strain showed significant differences between POD 14 both control 
and phosphate restriction and both diet groups of POD 21. POD 14 PI was significantly 
different from both diet groups of POD 35. POD 14 control was also significantly 
different from POD 14 PI diet group. There were also significant differences between 
both the control and PI groups for POD 21 and both diet groups of POD 35. The B6 
strain showed significant differences between POD 35 control and both the control and PI 
diet groups of POD 14. POD 21 PI diet group was significantly different from both diet 
groups of POD 14 and POD 14 control was significantly different from POD 14 PI diet 
group. C3 strain showed significant differences between control and PI diet groups and 
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both diet groups of POD 35. POD 14 PI diet group was also significantly different from 
both diet groups of POD 21. Control and PI diet groups were both significantly different 
from both diet groups of POD 35 and POD 35 control was significantly different from 
POD 35 PI diet group. Overall there was an increase among all three strains in the BMD 
as POD time increased. 
 
Figure 19. Bone Mineral Density Comparisons at POD 42. Comparisons of diet and strain at POD 42.  
 Comparison of POD 42 for diet and strain did not show any significant 
differences between the different strains. 
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Figure 20. Tissue Mineral Density Measurements of AJ, B6, and C3. Comparisons between POD and diet for all 
three strains are shown. Statistically significant differences are denoted with a line with a * connecting the points. 
 Tissue mineral density (TMD) is a measure of the average voxel density within 
the bone volume compartment of the callus. This measurement only contains mineralized 
tissue. This study excluded the canal and bone cortex. All three strains showed significant 
differences between POD and diet, which are depicted in figure 25. AJ strain showed 
many significant differences among diet and POD. POD 14 for both the control and PI 
diet groups were different from both diet groups of POD 35. Both diet groups of POD 14 
were significantly different from POD 21 control. Control and PI diet groups of POD 21 
were significantly different from both diet groups of POD 35. POD 14 control was 
significantly different from PI diet group of POD 21. The PI and control diets were 
significantly different from each other for both POD 14 and POD 21. B6 strain showed 
significant difference between control and PI diet for POD 14 and both diet groups of 
POD 35. POD 14 control was significantly different from POD 21 control and POD 14 PI 
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diet was significantly different from POD 21 PI diet. Both control and PI diet of POD 21 
were different from both diet groups of POD 35. The control and PI diet of both POD 21 
and POD 14 were significantly different from each other. The C3 strain POD 14 control 
and PI diet were significantly different from both diet groups of POD 42. POD 14 control 
was significantly different from POD 21 control and POD 14 PI was significantly 
different from both diet groups of POD 21. All three time points (14, 21, and 35) showed 
that the control and PI diet groups were significantly different from each other.  
 
Figure 21. Tissue Mineral Density Comparisons at POD 42. Comparisons of each strain against the normal and 
phosphate restricted diet groups at POD 42.  
 At POD 42 all three strains, AJ, B6, and C3 were compared for differences in the 
control and PI diet. No significant differences were found between all three strains of 
mice.  
Mechanical Testing Analysis 
 There were many factors that were significant from the mechanical testing results 
and in some cases there were significant interactions between the factors. For example 
POD is not significant for rigidity break but is significant when diet and/or strain were 
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taken into account. POD crossed with strain as well as POD crossed with diet and strain 
were significant for all mechanical testing factors. 
Table 3. Mechanical Testing ANOVA significance. Significant p-values are highlighted in yellow with p-value listed 
in the table for each measurement and cross.  
 
 
 
 
 
 
Figure 22. Max Torque for AJ, B6, and C3 Strain. These graphs show comparisons between the post operative day 
and strain. The lines with * above them represent significance between the particular time point and diet and the 
connected time point and diet. A line with a bar on the end represents that both diets at that time point are significant 
with the connected region by the line.  
Comparing the maximum torque required to break a callus within each strain of 
mice no significant differences were found in both AJ and B6 strains of mice. However 
	  	  
Max	  
Torque	  
[Nm]	  
Work	  to	  
Failure	  
[Nm-­‐rad]	  
Stiffness	  
Narrow	  
[Nm/rad]	  
Rigidity	  
Narrow	  
[N/rad]	  
Twist	  to	  
Failure	  
[rad]	  
Stiffness	  
Break	  
[Nm/rad]	  
Rigidity	  
Break	  
[N/rad]	  
POD	   <.0001	   <.0001	   <.0001	   <.0001	   <.0001	   <.0001	   0.0525	  
Strain	   <.0001	   0.0002	   <.0001	   <.0001	   0.0956	   <.0001	   <.0001	  
Diet	   <.0001	   <.0001	   0.3602	   0.8175	   0.002	   0.0003	   0.0001	  
POD*Strain	   0.0051	   0.0437	   0.0043	   0.0035	   0.0018	   <.0001	   <.0001	  
POD*Diet	   0.0155	   0.0157	   0.0233	   0.0923	   0.0028	   0.0009	   0.015	  
Strain*Diet	   0.0079	   0.0146	   0.1659	   0.0735	   0.0065	   0.1493	   <.0001	  
Strain*Diet*POD	   0.0009	   0.0001	   0.0275	   0.022	   0.0081	   <.0001	   <.0001	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the C3 strain showed some significance. POD 35 phosphate restricted, or PI, group was 
significantly different from both POD 14 and POD 42 PI and control groups. POD 35 PI 
was also significantly different from POD 35 control. In the C3 strain there is a trend of 
increasing maximum torque as the POD time increased. 
 
 
 
 
 
Figure 23. Work to Failure for AJ, B6, and C3. Comparisons between POD and diet are shown for each strain. 
Statistical significance is shown between specific time point and diet by a line with * connecting significant relations.  
Work to failure, or toughness, showed significant differences in both the B6 and 
C3 strains. The B6 strain showed statistically significant differences between the POD 14 
PI diet and POD 35 and POD 42 for both diets. There were also significant differences 
between POD 14 PI diet and POD 14 and POD 21 control diets. Overall for the AJ and 
B6 strains of mice there is a trend of decreasing toughness as the POD time increased.  
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Figure 24. Stiffness Narrow for AJ, B6, and C3. Comparisons between POD and diet for each strain are shown. 
Significance between POD and strains is depicted by a line with * above.  
 Stiffness narrow, or resistance to deformation, for showed that there was no 
significant difference in the either AJ or B6 strains among all POD time points. C3 
showed significant difference between POD 35 PI and POD 21 PI and both the control 
and PI POD 14. There was also significant difference between POD 42 control and POD 
14 PI. The C3 strain of mice showed a trend of increasing stiffness as the POD time 
increased.  
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Figure 25. Stiffness Break for AJ, B6, and C3. Comparisons for POD and diet are shown for the stiffness break 
measurement for each strain. Significance is shown with a line and a * above between a specific POD and diet. 
 When stiffness was calculated using the entire torque-deformation curve, no 
significant differences were found. Both the AJ and B6 strain did not show any 
significant differences between POD and diet however there were significant differences 
in the C3 strain. POD 35 PI showed significant differences between POD 14 (control and 
PI) as well as POD 21 PI group. There was also significant difference between POD 35 
PI and POD 42 (control and PI) and POD 35 control groups. POD 14 control was 
significantly different from both control and PI groups of POD 21. Lastly POD 42 control 
was significantly different from both the control and PI groups of POD 14. A trend of 
increasing stiffness for the C3 strain of mice was seen as the POD time increased. 
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Figure 26. Rigidity Narrow for AJ, B6, and C3. Comparisons between POD and diet for each strain are shown. 
Significance between POD and diet are shown by connected lines with * above.  
 Rigidity narrow, or the resistance to deformation taking into account the length of 
the sample and hence more standardized, showed that there were no significant 
differences between either the AJ or B6 strains. Significant difference was noted in the 
C3 strain among POD 35 PI and POD 14 (both control and phosphate restricted), POD 21 
PI, and POD 42 PI. There was also significant difference between POD 14 control and 
POD 42 control for the rigidity narrow measurement. Overall there was an increase in the 
resistance to deformation among all three strains as the POD time increased. 
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Figure 27. Rigidity Break for AJ, B6, and C3. Comparisons between POD and diet are shown for rigidity break 
measurement for each strain. Statistical significance is depicted by a line with a * above between POD and diet that are 
significantly different. A line with ** above represents that everything beneath the line is significantly different.  
 When rigidity was calculated using the whole torque-deformation curve there 
were some significant interactions. The AJ strain did not show any significant differences 
between POD and diet. B6 showed a lot of significances when comparing POD and diet. 
POD 14 control was statistically significant with POD 42, POD 35, and POD 21 for both 
the control and PI diets as well as with POD 14 PI. POD 14 PI group was statistically 
different from POD 21 and POD 35 control. POD 21 control is statistically different from 
POD 35 PI. POD 35 control is significantly different from POD 42 PI diet group. The C3 
strain showed significantly difference in POD 35 PI and POD 14 (control and PI), POD 
21 control, and POD 42 PI. The B6 strain showed a decreasing trend in rigidity as the 
POD time increased while the C3 strain showed an increase as POD time increased.  
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Figure 28. Twist at Failure for AJ, B6, and C3. Comparisons between POD and diet are shown for each strain. 
Significance between POD and diet are shown by a line with a * above between significant measurements. 
 Twist at failure, the angular displacement required to break the sample, was 
significant differences within each of the three strains showed significance for some of 
the POD and diet combinations. AJ strain was significant for POD 14 control to both the 
POD 35 and POD 42 PI diets. There was also significance between the POD 14 PI and 
POD 42 control group. B6 strain showed a lot of significance between POD 14 PI diet 
and POD 21, POD 35, and POD 42 for both the control and PI diets. Significance was 
also found between POD 14 PI and POD 14 control groups. C3 strain had significance 
only between POD 14 control and POD 35 and POD 42 control groups. Overall there was 
a trend of decreasing angular displacement required to break the sample for all three 
strains of mice as the POD time increased. 
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CECT Analysis 
 Qualitative assessment of the CECT images showed the presence of more 
cartilage at earlier time points for AJ and B6 (figure 27). C3 had the least amount of 
cartilage compared to AJ and B6. Within each time point, the PI samples had more 
cartilage than the control samples. 
 
Figure 29. Three Dimensional CECT Image Renderings. Three strains of mice at POD 14, 18, and 21 contrast scans 
are shown. Bone is show in white, fracture callus in yellow, and cartilage is shown in red. 
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DISCUSSION 
Overall Findings 
 The goal of this study was to examine the effect of genetic variation on fracture 
healing. This was assessed by fracture callus composition and mechanical strength of the 
bone in both normal and phosphate deficient mice. This study showed that there were 
differences among the three strains of mice in both callus composition and mechanical 
strength of the bone during the healing of the fracture. Previous studies have 
demonstrated that there are differences in the cellular process of fracture healing (AI-Aql 
et al., 2008) and even shown that there are specific bone traits for the different genetic 
strains of mice (Price, Herman, Lufkin, Goldman, & Jepsen, 2005). However it still 
remains unclear the differences in the mechanical properties of how these inbred mouse 
strains differ from one another and whether there are relations to the fracture callus 
composition and mechanical strength. 
Callus Composition 
 Micro-CT measurements were done to characterize the difference in fracture 
callus composition. Micro-CT images allowed the visualization of data for the CECT 
data. Total volume measurements of the fracture callus showed significant differences in 
both the B6 and C3 strains as the healing time progressed. There was a decrease in the 
total volume of the fracture callus, which can be attributed to the cartilaginous callus 
being mineralized and decreasing in size as more gets mineralized. This is also shown 
because significant differences are seen in AJ, B6, and C3 bone volume measurements. 
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More of the less mineralized tissue is required to support the animal but as the tissue is 
mineralize the callus total volume is reduced. There are no significant differences seen 
between the control and PI diets for the strains except for B6 at POD 21. This indicated 
that the PI diet for the most part regained the properties of the control diet once phosphate 
was added back into the diet. The mineralized volume fraction or BV/TV measurement 
also confirmed the earlier conclusion that as the fracture callus was allowed to heal 
longer there was a larger portion of mineralized bone in the fracture callus. AJ, B6, and 
C3 mice all showed that there was an increase in the mineralized volume fraction with 
the greatest difference in POD 14 to POD 42. It can also be noted that there was no 
significant difference between the control and PI diet groups for all three strains. This 
could potentially mean that once the phosphate was added back into the diet at POD 15 
the bones were able to recover quickly, however it is interesting to note that there is no 
difference in POD 14. The bone mineral density (BMD) for AJ, B6, C3 all showed 
significant differences as the fracture callus was allowed more time to heal. The overall 
measurement value was lower for BMD compared to TMD because it represents the 
average density of the entire callus and not just the density of the mineralized tissue 
within the callus. Also there were significant differences in both AJ and B6 POD 14 
control and PI diet groups. The PI diet group had a lower value from the control 
indicating that there was less mineralization present at the early time point in these 
strains. The differences were not seen in POD 21 and 35, which could potentially indicate 
that there was a recovery of healing once phosphate was returned to the diet. There was a 
significant difference in POD 35 C3 control and PI groups, however this difference was 
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not present at POD 14 or 21. This could potentially mean that the phosphate deficiency is 
not seen until healing is nearly complete in the C3 strain. The tissue mineral density 
(TMD) had a higher average value for all three strains because this measurement only 
accounts for the mineralized tissue within the callus. It was shown to have a significantly 
different increase within each strain as the fracture callus was allowed more time to heal. 
Within the AJ strain of mice there were significant differences between POD 14 control 
and PI diet groups indicating that there was less mineralization in the phosphate restricted 
mice. This observation was also seen in B6 and C3 mice for POD 14. AJ, B6 and C3 
strain mice also showed significant differences in control and PI diet TMD measurements 
at POD 21, indicating that once phosphate was returned to the diet there was not the same 
regain of mineralization. C3 strain mice also showed significant difference in control and 
PI mice at POD 35, however this is not seen in AJ or B6 mice, which could mean that 
there was a regain in mineralization seen between POD 21 and POD 35 for these strains 
that is not seen in C3.  
 Through CECT analysis the results that were described from mechanical testing 
and micro-CT analysis can be visualized. There appears to be smaller facture calluses in 
the PI diet group for all strains. Less cartilage seems to be present in later POD time 
points with the appearance of more cortical bone. Differences in the appearance of the 
fracture callus among the stains is also more apparent with the use of CECT. The B6 
strain appears to be a larger fracture callus, however there does not appear to be 
substantially more cartilage present in this strain of mice. The distribution of cartilage 
around the fracture callus was noteworthy in CECT analysis. Cartilage appeared to be 
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centrally located around the fracture gap. More cartilage was present near the fracture gap 
and less cartilage is present towards both the proximal and distal ends of the fracture 
callus. Previous studies have shown that the genes Sox9 and collagen type II alpha 1 
(COL2A1) are good predictors of chondrogenesis. These studies showed that the peak of 
gene expression for cartilage is around day 7 for both the AJ and B6 strains of mice 
(Hogue, 2014; Matheny, 2014). There was a delay in gene expression for C3 mice with 
the PI diet to day 10, which may explain why there was more cartilage found in this strain 
at later time points.  
Mechanical Properties of the Callus 
 When looking at the mechanical testing outcomes from the study it is seen that 
there are differences between the POD time points and the strength of the fracture callus. 
The maximum torque results showed that the longer the fracture is allowed to heal it 
recovers from the phosphate restricted diet quickly and regains strength shortly after the 
addition of phosphate back into the diet in the C3 strain. While AJ and B6 did not show 
any significant differences in max torque values there appears to be a trend towards 
regain of strength after phosphate returns to the diet just as is shown in the C3 mice. 
When looking at the degree to which the bone needed to be rotated for fracture at the 
fracture callus, or twist to failure, there was a trend of decreasing values as the POD time 
increased. The stiffness measurements for the strains of mice showed a trend of 
increasing values as the POD time increased. These two outcomes indicated that the 
callus was becoming stronger as the length of time the bone was allowed to heal 
increased. There were no significant differences found in all measurements, however 
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there was a trend seen that as the phosphate returned to the diet there was an increase in 
the regain of stiffness and rigidity in the callus. The results from the twist to failure 
measurement showed that as the fracture callus is allowed more time to heal there is a 
decrease in the angular displacement needed to fracture the callus. This trend is seen in 
all three strains of mice. It is also see that there is a regain of strength of the callus in this 
measurement between the control and PI diet as phosphate is added back into the diet. 
Both measures of stiffness resulted in similar outcomes although there were trends for 
increases in stiffness and rigidity as POD time increased. There is also a quick regain of 
strength in the PI diet group once phosphate was added back into the diet after day 15. 
Fewer differences were seen in the C3 rigidity break measurement however the 
significant differences still show a trend of increasing rigidity with increasing POD time 
point. B6 strain showed a decrease in fracture callus rigidity, as the callus was allowed to 
heal for a longer duration. By POD 35 the PI diet group showed a significant difference 
from that of POD 35 control diet leading to the conclusion that there was not as quick of 
a regain of rigidity once phosphate was added back into the diet. Previous studies have 
looked at the gene expression of osterix, which is a good predictor of mineralization. 
These studies have shown that there is a peak of gene expression around day 5 to 7 for AJ 
and B6 control strains of mice. There is a later peak for the control group of C3 mice 
occurring around day 14. The three strains of mice also showed a delay in gene 
expression for the PI group with peak expression occurring around day 18 for the AJ and 
B6 mice and day 21 for the C3 mice (Hogue, 2014; Matheny, 2014). This explains the 
difference in the mechanical properties for the strains of mice for the time points. 
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Limitations 
 During this study there were a few limitations that presented during analysis. 
When analyzing the mechanical testing data some distal fractures were present which had 
the potential to alter the data because the fractures were not all located in the same region 
of the bone. For this reason the distal and proximally fracture bones were excluded from 
our analysis, however there is the potential that some of the fractures used in the study 
were not in the same location. Fracture callus structure depended a lot on the orientation 
of the pin within the bone during healing. If the pin was bent during the fracture process 
this could lead to a bent fracture callus forming. These fracture calluses may not have the 
same mechanical properties of a straight fracture callus. Differences in the potting 
process gauge length were hopefully corrected for by rigidity. There is still the potential 
that an abnormally large or small gauge length could alter the mechanical properties, 
which would artificially decrease or increase the strength of the bone respectively.  
 During the micro-CT measurement analysis POD 42 presented the challenge of 
viewing the fracture callus clearly among all samples. For this reason only the inclusion 
contour was used when performing the analysis. This limited our comparisons to only 
using POD 14, 21 and 35 with a separate comparison only involving POD 42. To 
overcome this testing of non-fractured bone needs to be completed to better compare the 
mineralization, callus composition, and strength.  
 CECT analysis had the limitation of image subtraction. Image subtraction 
involved overlaying the pre and post-contrast scans on top of on another to calculate the 
cartilage present. If the bone bent at the fracture callus during incubation in the contrast 
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agent this prevented the proper alignment of the images and could lead to an artificial 
increase in cartilage present in that sample.  
Conclusions and Future Directions 
 Fracture healing is a complex process that involves many factors, which 
contribute to the regain of original properties. This study showed that there were 
differences in the strain and how each strain healed in terms of regaining the mechanical 
properties of the bone as well as the structure of the fracture callus. This study showed 
that there were differences in the control and phosphate restricted diet groups and how 
these groups within each strain affected the process of mechanical strength and fracture 
callus composition. The phosphate restricted diet group was able to recover fracture 
callus measures to the level of the control mice in most cases which showed that even 
though there was a return to normal despite the lack of phosphate. It is unclear still as to 
what effect this has on the mechanical testing results. In the future testing should be done 
on the contralateral, or bones with no fractures, to determine if there is a return to normal 
properties in the fractured bone regardless of diet constraints.  
 CECT measurements did not include all time points used in micro-CT analysis 
because there is not much visible cartilage past POD 21, in addition POD 10 CECT 
should be analyzed to determine if there is an effect on the fracture callus cartilage 
composition early in the healing process. This may allow researchers to get a clearer 
picture on the formation of cartilage in the fracture callus and how the callus undergoes 
change with and without phosphate in the diet.  
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 After excluding distal fractures, the number of samples for some of the groups 
was small and thus there is not enough power to detect differences, therefore there is the 
need for larger sample sizes. Histological data should also be collected to determine if 
there is an effect of phosphate on the cellular level of fracture healing.  
 In conclusion this study gave significant insight into many of the mechanical 
properties of three strains of inbred mice. Effects of phosphate deficiency on fracture 
healing were also shown in mechanical properties of bone and the fracture callus 
formation. Through this information much can be learned about the process of 
mineralization and recovery of the bone from deficient diets during fracture healing.  
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